Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease

• Published in: Clinica chimica acta Vol. 419; pp. 73 - 76
• Main Authors: Chuang, Wei-Lien, Pacheco, Josh, Zhang, X. Kate, Martin, Monica M., Biski, Chad K., Keutzer, Joan M., Wenger, David A., Caggana, Michele, Orsini, Joseph J.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 18.04.2013
• Subjects: Adolescent; Child; Child, Preschool; Disease Susceptibility; Dried Blood Spot Testing; HPLC–MS/MS; Humans; Infant; Infant, Newborn; Krabbe; Leukodystrophy, Globoid Cell - blood; Neonatal Screening; Newborn screening; Psychosine; Psychosine - blood; Risk Factors; GALC; Psychosine; HPLC–MS/MS; DBS; Krabbe; NYSKDC; Newborn screening; KD
• ISSN: 0009-8981; 1873-3492
• DOI: 10.1016/j.cca.2013.01.017

New York State has screened over 1.2million newborns for Krabbe disease, and we identified 4 newborns with infantile Krabbe disease. In addition, 6 other newborns were identified with very low galactosylcerebrosidase (GALC) activity. Because these patients remain asymptomatic, we investigated whether psychosine levels could be a useful marker for disease. HPLC–MS/MS methodology was used to determine the psychosine concentrations in dried blood spots (DBS) collected from the following cohorts: known Krabbe patients, screened babies that were determined to have infantile Krabbe disease, asymptomatic infants with low GALC activity, and normal controls. The psychosine concentrations from the known Krabbe patients ranged from 7 to 50ng/ml. Newborns identified by screening who were confirmed with infantile Krabbe disease ranged from 23 to 73ng/ml. Asymptomatic individuals with low GALC activity had concentrations ranging from 1.7 to 5.7ng/ml. Concentrations in newborns with normal GALC activity were all <3ng/ml. The psychosine concentrations in DBS from confirmed infantile patients are at least four times higher than the asymptomatic newborns and nearly an order of magnitude greater than normal newborns. Further studies are needed to determine if psychosine can be used as a predictor of disease status/progression in screen positive newborns. ► HPLC–MS/MS is used to quantify glucosylsphingosine and psychosine in dried blood spots (DBS). ► Infantile Krabbe disease (KD) patients had very elevated psychosine concentrations in DBS. ► Infants with very low GALC activities that were asymptomatic for KD had low psychosine in DBS. ► Additional studies are needed to determine if psychosine is a predictive marker for KD.